display
Politicians in Brussels and Berlin have called for information about the sluggish vaccine procurement in Europe.
They explained that to WELT AM SONNTAG.
The EU MP Rasmus Andresen (Greens) said: "It is highly problematic that the Federal Government, the EU Commission and the vaccine manufacturers do not inform MPs and the public transparently".
He asks the EU to have access to the minutes of the negotiation rounds.
In the Bundestag, health expert Gerhard Schinnenburg reports a need for parliamentary information.
With regard to the large number of orders placed by the Tübingen-based company Curevac, the FDP health expert explained that the development was behind schedule: There is "the suspicion that Germany may have preferred a company in which the federal government is involved in EU orders" .
Health Minister Jens Spahn (CDU) must quickly clarify “and make the vaccine ordering process transparent”.
Contrary to its own statements, Germany did not place any binding vaccine orders with fixed delivery dates.
Germany had invested 300 million euros in Curevac last year after the federal government learned of US interest in the company.
As research by WELT AM SONNTAG shows, among other things, Curevac himself spoke of a possible “technology transfer” to the federal government.
display
In addition, Tübingen's Mayor Boris Palmer (Greens) had warned Spahn in a message: The then US President Donald Trump wanted the company to be relocated to the USA.
Then only the USA should be supplied.
With a view to a time frame for a possible approval for a vaccine, Curevac has now announced that it is considered "possible in the second quarter of 2021".
You can read the research on this news in WELT AM SONNTAG. We will be happy to deliver them to your home on a regular basis.
Source: Welt am Sonntag